This Case is about FINANCIAL MANAGEMENT, LEADERSHIP, OPERATIONS MANAGEMENT, POLICY, PROJECT MANAGEMENT, STRATEGIC PLANNING
PUBLICATION DATE: March 07, 2008 PRODUCT #: HKS482-HCB-ENG
Possibly the most extensively discussed EXCURSIONS-related problem was the discussion over the impact of the deal on attempts in order to improve public health in the developing world. Some developing countries maintained that EXCURSIONS patent rules prevented them from having access to vital medications, problems that were intensified by the dramatic rise in the prevalence of HIV/AIDS. Non-profit organizations such as Doctors without Borders accused drug companies of placing “patents over individuals.” Discussions ensued at the WTO to address these issues. HKS Case Number 1736.3
Related Case Solutions:
TRIPS Part II: International Trade meets Public Health: TRIPS and Access to Medicines Abridged
International Trade Meets Intellectual Porperty: The Making of the TRIPS Agreement (Abridged)
International Trade Meets Intellectual Property: The Making of the TRIPS Agreement (Abridged)
Stalemate at the WTO: TRIPS Agricultural Subsidies and the Doha Round
Stalemate at the WTO: TRIPS, Agricultural Subsidies, and the Doha Round
Merck: Global Health and Access to Medicines
Merck: Global Health and Access to Medicines
Agricultural Biotechnology Meets International Trade (A)
Agricultural Biotechnology Meets International Trade (B)
NICE or Nasty? Access and Reimbursement of Multiple Sclerosis Medicines in the UK